See our latest publication demonstrating MISPA's ability to predict vaccine responses
Multiplexed In-solution Protein Array [MISPA]
- MISPA is a patented many to many solution for immunoassays capable of screening > 250 targets against 1,000s of samples simultaneously .
- MISPA is a marriage between Next Gen Sequencing and Immunology.
- Getting results faster, with higher precision, comprehensive and quantitative responses at a lower cost vs standard ELISA
MISPA Advantages
- MISPA demonstrates an expanded dynamic range
- MISPA has increased signal/background ratios
- MISPA is highly reproducible
- MISPA is highly scalable